INHIBITION OF CYCLIC-AMP ACCUMULATION IN INTACT NCB-20 CELLS AS A DIRECT RESULT OF ELEVATION OF CYTOSOLIC CA2+

被引:26
作者
GARRITSEN, A [1 ]
ZHANG, YX [1 ]
FIRESTONE, JA [1 ]
BROWNING, MD [1 ]
COOPER, DMF [1 ]
机构
[1] UNIV COLORADO, HLTH SCI CTR,DEPT PHARMACOL,BOX C236, 4200 E 9TH AVE, DENVER, CO 80262 USA
关键词
D O I
10.1111/j.1471-4159.1992.tb10992.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Earlier studies established that adenylyl cyclase in NCB-20 cell plasma membranes is inhibited by concentrations of Ca2+ that are achieved in intact cells. The present studies were undertaken to prove that agents such as bradykinin and ATP, which elevate the cytosolic Ca2+ concentration ([Ca2+]i) from internal stores in NCB-20 cells, could inhibit cyclic AMP (cAMP) accumulation as a result of their mobilization of [Ca2+]i and not by other mechanisms. Both bradykinin and ATP transiently inhibited [H-3]cAMP accumulation in parallel with their transient mobilization of [Ca2+]i. The [Ca2+]i rise stimulated by bradykinin could be blocked by treatment with thapsigargin; this thapsigargin treatment precluded the inhibition of cAMP accumulation mediated by bradykinin (and ATP). A rapid rise in [Ca2+]i, as elicited by bradykinin, rather than the slow rise evoked by thapsigargin was required for inhibition of [H-3]cAMP accumulation. Desensitization of protein kinase C did not modify the inhibitory action of bradykinin on [H-3]cAMP. Effects of Ca2+ on phosphodiesterase were also excluded in the present studies. The accumulated data are consistent with the hypothesis that hormonal mobilization of [Ca2+]i leads directly to the inhibition of cAMP accumulation in these cells and presumably in other cells that express the Ca2+-inhibitable form of adenylyl cyclase.
引用
收藏
页码:1630 / 1639
页数:10
相关论文
共 36 条
[1]  
BOYAJIAN CL, 1991, J BIOL CHEM, V266, P4995
[2]   POTENT AND COOPERATIVE FEEDBACK INHIBITION OF ADENYLATE-CYCLASE ACTIVITY BY CALCIUM IN PITUITARY-DERIVED GH3 CELLS [J].
BOYAJIAN, CL ;
COOPER, DMF .
CELL CALCIUM, 1990, 11 (04) :299-307
[3]  
BROWN JH, 1984, J BIOL CHEM, V259, P3777
[4]   CHARACTERIZATION OF BRADYKININ-INDUCED PHOSPHOINOSITIDE TURNOVER IN NEUROHYBRID NCB-20 CELLS [J].
CHUANG, DM ;
DILLONCARTER, O .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (02) :505-513
[5]   CALCIUM INHIBITION OF CARDIAC ADENYLYL CYCLASE - EVIDENCE FOR 2 DISTINCT SITES OF INHIBITION [J].
COLVIN, RA ;
OIBO, JA ;
ALLEN, RA .
CELL CALCIUM, 1991, 12 (01) :19-27
[6]  
COOPER DMF, 1991, BIOCHEM J, V278, P903
[7]   INHIBITION OF CAMP ACCUMULATION BY INTRACELLULAR CALCIUM MOBILIZATION IN C6-2B CELLS STABLY TRANSFECTED WITH SUBSTANCE-K RECEPTOR CDNA [J].
DEBERNARDI, MA ;
SEKI, T ;
BROOKER, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (20) :9257-9261
[8]   BRADYKININ ACTIVATES PROTEIN KINASE-C IN CULTURED CORTICAL COLLECTING TUBULAR CELLS [J].
DIXON, BS ;
BRECKON, R ;
FORTUNE, J ;
SUTHERLAND, E ;
SIMON, FR ;
ANDERSON, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (05) :F808-F817
[9]  
EVANS T, 1984, MOL PHARMACOL, V26, P395
[10]  
GARRITSEN A, 1992, MOL PHARMACOL, V41, P743